Work

First-in-human, first-in-class phase 1a study of BXQ-350 for solid tumors and gliomas.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.2517

Authors: Olivier Rixe, John Charles Morris, Vinay K. Puduvalli, John L. Villano, Trisha Michel Wise-Draper, Carolyn Muller, Angela N. Johnson, Robert Wesolowski, Xiaoyang Qi

Institutions: UNM Comprehensive Cancer Center, University of Cincinnati, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, University of Kentucky, Markey Cancer Center, Clinical Trial and Consulting, The Ohio State University

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891965065

Cites:

Cited by: 9

Related to: 10